Compare UK prices. 40+ products · 17 retailers scored
PeptideClear UK

FAQ · Research peptides

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protein originally identified in human gastric juice. The Sikiric research group at the University of Zagreb has published most of the preclinical literature on it since 2003, primarily on tendon healing, gut barrier integrity, and tissue repair in rodent models. No human phase II or phase III trials have been published. In the UK, BPC-157 has no marketing authorisation as a medicine and is sold by UK retailers under "research use only, not for human or animal consumption" framing.

The discovery

Predrag Sikiric and colleagues at the University of Zagreb identified BPC (Body Protection Compound) in human gastric juice in the 1990s. BPC-157 is a 15-amino-acid synthetic fragment of the larger native compound. The "157" refers to the specific sequence of amino acids. The Sikiric group has published several hundred preclinical papers on BPC-157 since 2003, most in rodent injury and tissue-repair models.

What the preclinical literature shows (in animals)

Most of the literature comes from a single research group. Independent replication outside the Sikiric group is limited. None of the rodent findings has been confirmed in randomised human clinical trials.

UK regulatory status

Related: BPC-157 encyclopedia · UK retailers · BPC-157 vs TB-500 · Research use only framing.

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-05-20